The global conjugate vaccine market is anticipated to grow with the CAGR of 13.4% during the forecast period 2018-2023. Conjugate vaccines are similar to recombinant vaccines manufactured by the combination of two different components. Conjugate vaccines, however, are made by pieces from the coats of bacteria. These coats are chemically linked to a carrier protein, and the combination is used as a vaccine. Conjugate vaccines are used to create a more powerful, combined immune response from infectious diseases. The vaccines currently in use for children against pneumococcal bacterial infections are made using this technique. Haemophilus influenza type B (Hib) Vaccine, pneumococcal vaccine and meningococcal vaccine are some of the examples of conjugate vaccines.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @ https://www.omrglobal.com/request-sample/conjugate-vaccine-market
The factors fuelling the growth of the conjugate vaccine market includes the increasing demand of meningococcal vaccines and pneumococcal. The increasing prevalence of infectious disease and rising awareness is estimated to boost the growth of the market. According to the U.S. National Library of Medicine, National Institutes of Health, the highest mortality cases reported were due to vaccine preventable diseases. High-income countries accounting for 87% of the population of have pneumococcal conjugate vaccines in their immunization schedules, whereas only 2% had pneumococcal conjugate vaccines in their immunization schedules among the total population of low-income countries.
A Full Report of Global Conjugate Vaccine Market is Available at: https://www.omrglobal.com/industry-reports/conjugate-vaccine-market
The market study of conjugate vaccines market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Global Conjugate Vaccine Market – Company Profiles
- Astellas Pharma
- Astrazeneca
- Bharat Biotech
- Biological E Ltd.
- Csl Behring
- Glaxosmithkline Plc.
- Mitsubishi Tanabe Pharma
- Novartis Ag
- Neuron Biotech
- Merck & Co.
- Pfizer
Global Conjugate Vaccine Market- Segmentation
By Type
- Multivalent Conjugate Vaccines
- Monovalent Conjugate Vaccines
By Disease
- Meningococcal,
- Diphtheria Tetanus Pertussis,
- Influenza,
- Pneumococcal,
- Others
By Patient Type
- Adults
- Children
Global Conjugate Vaccine Market- Regions
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Latin America
- Middle East & Africa
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/conjugate-vaccine-market
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
